Table 1.
n | Sex | Age at Diagnosis (year) | Observation Period (year) | Symptoms at Onset | Liver Signs at Onset |
Aldo B Mutation | Fructose Intake mg/day |
---|---|---|---|---|---|---|---|
1 * | M | 0.3 | 4.9 | - | B | p.A175D/p.A175D | 0 |
2 | M | 0.9 | 7.6 | 1 | A-B | p.A175D/p.A175D | 0 |
3 | F | 0.6 | 21.1 | 2-4 | A-B | p.A175D/p.Y204 * | 165 |
4 | F | 1.1 | 14.9 | 1 | A-B | p.A175D/p.A175D | 223 |
5 | M | 0.8 | 9.7 | - | A-B | p.Y204 */p.Y204 * | 354 |
6* | M | 0.8 | 13.9 | 2-3-4 | A-B | p.A150P/p.A175D | 223 |
7 | M | 2 | 14.6 | 4 | A-B | p.A150P/p.A175D | 223 |
8 | F | 0.6 | 19.2 | 1 | A-B | p.A175DP/p.A175D | 137 |
9 | M | 1 | 14.2 | 2 | B | p.A150P/p.A150P | 67 |
10 | M | 0.9 | 6.6 | 2-4 | - | p.A150P/p.A175D | 35 |
11 | M | 0.9 | 10.5 | 1 | A-B | p.A150P/p.A175D | 723 |
12 | F | 1.5 | 11.9 | 2-4 | A | p.A150P/p.A150P | 223 |
13 | F | 2.2 | 11.7 | 1 | A-B | p.A150P/p.A150P | 223 |
14 * | F | 0 | 7.2 | - | A-B | p.A150P/p.A150P | 91 |
15 | M | 2.2 | 19.8 | 1 | A-B | p.N120Kfs */p.N120Kfs * | 91 |
16 | M | 1 | 4.3 | 1 | A-B | p.A175D/p.L289Ffs * | 45 |
17 | F | 3 | 16.5 | 1 | A-B | p.L257P/p.N335K | 40 |
18 | F | 18.5 | 4.5 | 1-4 | B | p.A150P/p.A150P | 104 |
19 * | M | 0 | 17 | 1-2-3 | B | p.A150P/p.A150P | 253 |
20 | F | 4 | 18.2 | 1 | - | p.A175D/-? | 270 |
21 | M | 1 | 6.6 | 1 | A-B | p.A150P/p.A150P | 160 |
22 | F | 3 | 13.2 | 1 | B | p.A175D/p.A175D | 163 |
23 * | F | 0 | 9.8 | - | B | p.Y204 */p.Y204 * | 154 |
24 | F | 0.5 | 16.3 | 1 | B | p.A175D/p.Y204 * | 109 |
25 * | M | 0 | 12.1 | - | - | p.A150P/p.A175D | 223 |
26 | M | 2.1 | 4.3 | 1 | A-B | p.A175D/p.A175D | 46 |
27 | F | 0.6 | 6.9 | 1-3 | A-B | p.A150P/p.A150P | 91 |
28 | M | 0.7 | 6.3 | 4 | A-B | p.A150P/p.Y204 * | 325 |
29 | F | 10.8 | 15.2 | - | B | p.A150P/p.Y204 * | 198 |
30 | F | 1 | 11.4 | 1 | B | p.A150P/p.A175D | 247 |
31 | F | 4.7 | 5.6 | 1-2 | - | p.A150P/p.A175D | 91 |
32 * | M | 0.2 | 8.6 | - | - | p.A150P/p.A175D | 91 |
33 | F | 0.5 | 4.2 | 2-4 | - | p.A150P/p.A175D | 0 |
34 | F | 0.3 | 6.7 | 2-4 | - | p.Y204 */p.N335K | 46 |
35 | F | 0.3 | 3.2 | 2-4 | B | p.A150P/p.A150P | 182 |
36 | M | 0.5 | 24.5 | 1-2-3 | - | p.A150P/p.A150P | 650 |
37 | F | 12 | 3.5 | 2 | - | p.Y204 */p.Y204 * | 110 |
38 | F | 7.5 | 4 | 2 | - | p.A150P/p.A150P | 91 |
39 | M | 5 | 4.1 | 1 | A-B | p.A150P/p.A175D | 6 |
40 | M | 1.3 | 5 | 4 | A-B | p.A150P/c.1_624del | 181 |
41 | M | 4 | 1.8 | 1 | B | p.A150P/p.A150P | 46 |
42 | M | 0.7 | 16.9 | - | A-B | p.A150P/p.A150P | 137 |
43 | M | 0.7 | 14.8 | - | B | p.A150P/p.A150P | 199 |
44 | F | 8 | 4 | 2 | - | p.A175D/p.L289Ffs * | 235 |
45 | F | 2 | 10.2 | 1 | A-B | p.A150P/p.A175D | 434 |
46 | M | 0.7 | 11.4 | 1-2-4 | A-B | p.A175D/p.L229P | 91 |
47 | F | 3 | 10.2 | 1 | - | p.A150P/p.N120Kfs * | 110 |
48 | F | 5.5 | 6.2 | 1 | A-B | p.A175D/p.N335K | 206 |
* older sibling affected. 1 sweet aversion; 2 vomit; 3 diarrhea, 4 hypoglycemia; A hypertransaminasemia, B US diagnosis of liver steatosis. M = male, F = female.